Last update :
03/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
References   References 3632  
Type : Manufacturer
Research teams :
Authors :
Title : Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
Reference : Hospira 2017
Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 
List of drugs
InjectionEpirubicin hydrochloride Anticancer drug
Factors which affect stability PH PH >7 Induces Degradation
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 2-8°C Not specified
84 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 25 °C Not specified
14 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 2-8°C Not specified
84 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 25 °C Not specified
14 Day
Incompatible + InjectionHeparin sodium
Incompatible + InjectionSodium bicarbonate
Incompatible + NaHCO3
InjectionHeparin sodium Anticoagulant
Incompatible + InjectionEpirubicin hydrochloride
InjectionSodium bicarbonate Electrolyte
Incompatible + InjectionEpirubicin hydrochloride
  Mentions Légales